What is Docetaxel-carboplatin-trastuzumab (TCH)?

Category: Prescription Drugs


See also: Carboplatin Docetaxel Trastuzumab

Docetaxel-carboplatin-trastuzumab, also known as TCH, is a regimen that may be used for the treatment of breast cancer. It contains the anticancer agents docetaxel (Taxotere®), carboplatin, and trastuzumab (Herceptin®).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Docetaxel-carboplatin-trastuzumab (TCH)

Side effect Patients Percentage
Diarrhea 1
Fatigue 1
Fever/chills 1

Why patients stopped taking Docetaxel-carboplatin-trastuzumab (TCH)

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 1
See 1 patient who's stopped taking Docetaxel-carboplatin-trastuzumab (TCH)


Stopped taking Docetaxel-carboplatin-trastuzumab (TCH)

Duration Patients Percentage
1 - 6 months 1
Last updated:
There are no evaluations for Docetaxel-carboplatin-trastuzumab (TCH).